Stula D, Gratzl O
Zentralbl Neurochir. 1979;40(4):343-5, 347-8.
From the Clinic of Neurosurgery of the Kantonsspital Basle a report is given over a one year-experience with a CO2-Sharplan 791 Laser (Prod.: Laser Industrie Ltd., Israel). The excellent technical qualities, as described by other authors, have been confirmed. 11 patients with malignant glioma received all the same treatment (intratumoral partly resection and "vaporisation" of the tumor-bed with Laser-ray followed by radiotherapy with 6000 rad.). It showed that the post-operative course and the definite prognosis of the disease is not decisive different from the results of an operative treatment with conventional methods. Only 2 (18,1%) patients were in a satisfactory condition fourty weeks after operation and radiotherapy. 5 patients (45,4%) died in the first 10 months after operation and radiotherapy and 4 (36,3%) had a relapse 6 months after surgical intervention.
巴塞尔州立医院神经外科诊所报告了使用CO2-Sharplan 791激光(生产商:以色列激光工业有限公司)的一年经验。其他作者所描述的出色技术品质得到了证实。11例恶性胶质瘤患者接受了相同的治疗(肿瘤内部分切除,用激光束对肿瘤床进行“汽化”,随后进行6000拉德的放射治疗)。结果表明,该疾病的术后病程和最终预后与传统手术治疗结果并无决定性差异。术后放疗40周后,只有2例(18.1%)患者状况良好。5例(45.4%)患者在术后放疗的前10个月内死亡,4例(36.3%)在手术干预6个月后复发。